Evelyne Vinet

Montreal, QC, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 90 publications

The lupus damage index revision program: Results from the item generation and reduction phases.

The lupus damage index revision program: Results from the item generation and reduction phases.

Journal: Lupus science & medicine

Published: July 30, 2026

ERN ReCONNET-SLICC-SLEuro consensus on the therapeutic management of rare systemic lupus erythematosus manifestations (part 2).

ERN ReCONNET-SLICC-SLEuro consensus on the therapeutic management of rare systemic lupus erythematosus manifestations (part 2).

Journal: The Lancet. Rheumatology

Published: February 17, 2026

Diarrhoea events in offspring exposed to tumour necrosis factor inhibitors and rotavirus vaccine: a population-based cohort study.

Diarrhoea events in offspring exposed to tumour necrosis factor inhibitors and rotavirus vaccine: a population-based cohort study.

Journal: Rheumatology (Oxford, England)

Published: January 06, 2026

Increased Risk of Intrahepatic Cholestasis of Pregnancy in SLE Women Exposed to Azathioprine.

Increased Risk of Intrahepatic Cholestasis of Pregnancy in SLE Women Exposed to Azathioprine.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: December 11, 2025

The Lupus Damage Index Revision Program: Results From the Item Generation and Reduction Phases.

The Lupus Damage Index Revision Program: Results From the Item Generation and Reduction Phases.

Journal: Arthritis care & research

Published: November 14, 2025

A Global Survey of Quinacrine Use in Systemic and Cutaneous Lupus Erythematosus.

A Global Survey of Quinacrine Use in Systemic and Cutaneous Lupus Erythematosus.

Journal: The Journal of rheumatology

Published: November 04, 2025

Forgotten costs of systemic lupus erythematosus: estimating indirect healthcare costs in a national prospective observational Canadian lupus cohort.

Forgotten costs of systemic lupus erythematosus: estimating indirect healthcare costs in a national prospective observational Canadian lupus cohort.

Journal: Lupus science & medicine

Published: October 17, 2025

Artificial Intelligence-based Online Symptom Assessment Tools for Systemic Lupus Erythematosus (SLE) diagnosis: Patient Perspectives.

Artificial Intelligence-based Online Symptom Assessment Tools for Systemic Lupus Erythematosus (SLE) diagnosis: Patient Perspectives.

Journal: Arthritis care & research

Published: October 15, 2025

Patient perspectives on clinical trial participation for novel advanced therapies: a focus group study in systemic lupus erythematosus.

Patient perspectives on clinical trial participation for novel advanced therapies: a focus group study in systemic lupus erythematosus.

Journal: Rheumatology international

Published: September 03, 2025

Serious Infections in Offspring Exposed to Tumor Necrosis Factor Inhibitors During Pregnancy: Comparison of Timing During Pregnancy and Placental Transfer Ability.

Serious Infections in Offspring Exposed to Tumor Necrosis Factor Inhibitors During Pregnancy: Comparison of Timing During Pregnancy and Placental Transfer Ability.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: June 23, 2025

Patterns of Use and Discontinuation for Tumor Necrosis Factor Inhibitors in Pregnant Women: Insights From a Real-World Sample.

Patterns of Use and Discontinuation for Tumor Necrosis Factor Inhibitors in Pregnant Women: Insights From a Real-World Sample.

Journal: The Journal of rheumatology

Published: June 02, 2025

Tumor Necrosis Factor Inhibitors and Risk of Serious Infections in Pregnant Women With Chronic Inflammatory Diseases.

Tumor Necrosis Factor Inhibitors and Risk of Serious Infections in Pregnant Women With Chronic Inflammatory Diseases.

Journal: ACR open rheumatology

Published: March 12, 2025

Showing 1-12 of 90

Last Updated: 09/26/2026